Related Experiment Video
Updated: Feb 28, 2026

03:08
Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization
Published on: October 3, 2025
1.0K
Discovery of Disease Relationships via Transcriptomic Signature Analysis Powered by Agentic AI.
1School of Information Sciences, University of Illinois Urbana-Champaign, Urbana, IL, USA, kec10@illinois.edu.
Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing
|February 27, 2026
Summary
This study uses AI and transcriptomics to uncover hidden molecular links between diseases, revealing new therapeutic opportunities and understanding disease mechanisms beyond clinical symptoms.
Area of Science:
- Genomics
- Computational Biology
- Systems Biology
Background:
- Current disease classification often misses molecular similarities due to varied clinical presentations.
- Understanding molecular connections is crucial for novel therapeutic strategies.
Purpose of the Study:
- To develop a transcriptomics-driven framework for discovering disease relationships.
- To identify molecular commonalities and functional convergence across diverse diseases.
- To explore therapeutic repurposing opportunities and underlying molecular mechanisms.
Main Methods:
- Utilized GenoMAS, an automated agentic AI system, to analyze over 1,300 disease-condition pairs.
- Developed a novel pathway-based similarity framework integrating multi-database enrichment analysis.
- Constructed a disease similarity network based on transcriptomic data.
Main Results:
- Identified robust gene-level overlaps and novel cross-category disease links.
- Revealed shared biological pathways suggesting functional convergence and molecular mechanisms.
- Demonstrated how background conditions modulate transcriptomic similarity and identified therapeutic repurposing candidates.
Conclusions:
- Agentic AI can scale transcriptomic analysis for mechanistic interpretation across complex disease landscapes.
- The framework facilitates discovery of non-obvious disease relationships and therapeutic targets.
- Publicly accessible data enables further research into disease molecular underpinnings.
More Related Videos
Related Concept Videos
Genomics
41.1K
Genomics is the science of genomes: it is the study of all the genetic material of an organism. In humans, the genome consists of information carried in 23 pairs of chromosomes in the nucleus, as well as mitochondrial DNA. In genomics, both coding and non-coding DNA is sequenced and analyzed. Genomics allows a better understanding of all living things, their evolution, and their diversity. It has a myriad of uses: for example, to build phylogenetic trees, to improve productivity and...
41.1K
Pharmacogenomics: Identification of New Drug Targets
53
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
53
Genome-wide Association Studies-GWAS
16.0K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
16.0K

